deferoxamine has been researched along with 2-amino-4-hydroxy-6-formylpteridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Endo, N; Fukuda, K; Hirota, K; Ishii, H; Makino, K; Mori, H; Sasada, M; Yamashita, K | 1 |
| Arai, T; Hirota, K; Kodaki, T; Makino, K; Miyoshi, T; Mori, H; Sasada, M; Sommani, P; Tsunemine, H; Yamashita, K | 1 |
2 other study(ies) available for deferoxamine and 2-amino-4-hydroxy-6-formylpteridine
| Article | Year |
|---|---|
6-formylpterin, a xanthine oxidase inhibitor, intracellularly generates reactive oxygen species involved in apoptosis and cell proliferation.
Topics: Apoptosis; Catalase; Cell Division; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Electrochemistry; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; fas Receptor; HL-60 Cells; Humans; Hydrogen Peroxide; Jurkat Cells; NAD; Nucleotides; Oxidation-Reduction; Oxygen Consumption; Pteridines; Pterins; Reactive Oxygen Species; Superoxides; Xanthine Oxidase | 2001 |
Inhibitory effect of 6-formylpterin on HIF-1alpha protein accumulation.
Topics: Acetylcysteine; Antioxidants; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Deferoxamine; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Pterins; Reactive Oxygen Species; RNA, Messenger | 2007 |